ImmunoVec

Santa Monica, United States

ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.

Sep 2025

Grant

Top Investors

Advanced Research Projects Agency for HealthCalifornia Institute for Regenerative Medicine

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are ImmunoVec's investors?

ImmunoVec's investors include Advanced Research Projects Agency for Health, California Institute for Regenerative Medicine.

Where is ImmunoVec headquartered?

ImmunoVec is headquartered in Santa Monica, United States.

What does ImmunoVec do?

ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.

What stage is ImmunoVec at?

ImmunoVec is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"ImmunoVec — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/immunovec. Accessed July 1, 2026.

APA

VCBacked. (2025). ImmunoVec — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/immunovec

Wikipedia (cite web)

{{cite web |title=ImmunoVec — Funding & Investors |url=https://www.vcbacked.co/company/immunovec |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.